These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 35813900)

  • 1. Vasopressin versus norepinephrine as the first-line vasopressor in septic shock: A systematic review and meta-analysis.
    Sedhai YR; Shrestha DB; Budhathoki P; Memon W; Acharya R; Gaire S; Pokharel N; Maharjan S; Jasaraj R; Sodhi A; Kadariya D; Asija A; Kashiouris MG
    J Clin Transl Res; 2022 Jun; 8(3):185-199. PubMed ID: 35813900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.
    Taylor A; Jones T; Forehand CC; Smith SE; Dykes H; Newsome AS
    J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Ragoonanan D; Nickelsen P; Tran N; Allen B; Emborski R; Legare A; Villela A; Hampson L; Busey K; Shomo E; Broomfield A; Hailu K
    J Intensive Care Med; 2024 Apr; 39(4):306-312. PubMed ID: 37715634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin for Septic Shock in a Medical-Surgical Intensive Care Unit.
    Patel A; Beauchesne A; Bredenkamp N; McGloin R; Stabler SN; Boyce K
    Can J Hosp Pharm; 2020; 73(3):209-215. PubMed ID: 32616947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of early and late norepinephrine administration in patients with septic shock: a systematic review and meta-analysis.
    Ahn C; Yu G; Shin TG; Cho Y; Park S; Suh GY
    Chest; 2024 Jul; ():. PubMed ID: 38972348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INITIATION TIMING OF VASOPRESSOR IN PATIENTS WITH SEPTIC SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Ye E; Ye H; Wang S; Fang X
    Shock; 2023 Nov; 60(5):627-636. PubMed ID: 37695641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis.
    Jiang L; Sheng Y; Feng X; Wu J
    Crit Care; 2019 Mar; 23(1):91. PubMed ID: 30871607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis.
    Yao RQ; Xia DM; Wang LX; Wu GS; Zhu YB; Zhao HQ; Liu Q; Xia ZF; Ren C; Yao YM
    Front Pharmacol; 2020; 11():563. PubMed ID: 32435192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concomitant use of ultra short beta-blockers with vasopressors and inotropes in critically ill patients with septic shock: A systematic review and meta-analysis of randomized controlled trials.
    Al Sulaiman K; Alkofide HA; AlFaifi ME; Aljohani SS; Al Harthi AF; Alqahtani RA; Alanazi AM; Nazer LH; Al Shaya AI; Aljuhani O
    Saudi Pharm J; 2024 Jun; 32(6):102094. PubMed ID: 38812943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative safety and efficacy of vasopressors for mortality in septic shock: A network meta-analysis.
    Nagendran M; Maruthappu M; Gordon AC; Gurusamy KS
    J Intensive Care Soc; 2016 May; 17(2):136-145. PubMed ID: 28979478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin in vasoplegic shock in surgical patients: systematic review and meta-analysis.
    Szeles TF; Almeida JP; Cruz JASD; Artifon ELA
    Acta Cir Bras; 2023; 38():e387523. PubMed ID: 38055405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Response to Third-Line Angiotensin-II vs Epinephrine in Septic Shock: A Propensity-Matched Cohort Study.
    Blankenship CR; Betthauser KD; Hencken LN; Maamari JA; Goetz J; Giacomino BD; Gibson GA
    Ann Pharmacother; 2024 Feb; ():10600280231226132. PubMed ID: 38303571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review.
    Zhou HX; Yang CF; Wang HY; Teng Y; He HY
    World J Crit Care Med; 2023 Sep; 12(4):204-216. PubMed ID: 37745258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine only regimen for long-term sedation is associated with reduced vasopressor requirements in septic shock patients: A retrospective cohort study from MIMIC-IV database.
    Li L; Shi X; Xiong M; Kong K; Chen Z; Zhou S; Zeng Z; An S; Xu B
    Front Med (Lausanne); 2023; 10():1107251. PubMed ID: 36923011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition.
    Guinot PG; Martin A; Berthoud V; Voizeux P; Bartamian L; Santangelo E; Bouhemad B; Nguyen M
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin in Sepsis and Other Shock States: State of the Art.
    García-Álvarez R; Arboleda-Salazar R
    J Pers Med; 2023 Oct; 13(11):. PubMed ID: 38003863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Albumin Replacement on Vasopressor Duration in Septic Shock in Patients With Hypoalbuminemia.
    Counts JP; Arnold J; Atyia S; Ogake S; Smith RM; Doepker B
    Ann Pharmacother; 2024 Mar; ():10600280241236507. PubMed ID: 38486351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II in the treatment of distributive shock: a systematic-review and meta-analysis.
    Xourgia E; Exadaktylos AK; Chalkias A; Ziaka M
    Shock; 2024 Jun; ():. PubMed ID: 38888542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of dynamic arterial elastance for vasopressor withdrawal: a systematic review and meta-analysis.
    Alvarado-Sánchez JI; Salazar-Ruiz S; Caicedo-Ruiz JD; Diaztagle-Fernández JJ; Cárdenas-Bolivar YR; Carreño-Hernandez FL; Mora-Salamanca AF; Montañez-Nariño AV; Stozitzky-Ríos MV; Santacruz-Herrera C; Ospina-Tascón GA; Pinsky MR
    Ann Intensive Care; 2024 Jul; 14(1):108. PubMed ID: 38980442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions regarding vasopressin use and practices in septic shock, and cost containment strategies.
    Hammond DA; Rech MA; Daley MJ; Devlin JW; Hodge EK; Kooda KJ; Lat I; Personett HA; Roberts R; Sacha G; Stollings JL; Swanson JM; Bauer SR
    J Am Coll Clin Pharm; 2019 Jun; 2(3):257-267. PubMed ID: 38213315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.